About Proteas Bioanalytics
Proteas Bioanalytics is a private company based in Torrance, California, incorporated in 2020 in Delaware. It has reported $1,785,000 raised in two offerings on Form D since November 2020. Its chief executive is Spiros Garbis.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 11, 2022 | Mar 13, 2023 | $365,000of $3.0M target | 5 | $73,000 | Debt, OptionsRule 506(b) | Form D ↗ |
| Oct 31, 2020 | Nov 9, 2020amended Nov 10, 2021 | $1,420,000of $4.0M target | 7 | $202K | Debt, OptionsRule 506(b) | Form D/A ↗1 earlier filing |
| Total, two offerings | $1,785,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Proteas Bioanalytics's Form D filed Mar 13, 2023.
VD
Valerie Darling
Director
First appears on the Form D that Proteas Bioanalytics filed on March 13, 2023; on 1 of its 3 filings.
SG
Spiros Garbis
Chief Executive Officer and director
On every Form D that Proteas Bioanalytics has filed: 3 filings, from Nov 9, 2020 to Mar 13, 2023.
AM
Antigoni Manousopoulou
Director
First appears on the Form D that Proteas Bioanalytics filed on March 13, 2023; on 1 of its 3 filings.
Earlier filings also listed
- Keith Hoffman · directorLast listed on the amended Form D that Proteas Bioanalytics filed on November 10, 2021; on 1 of its 3 filings.
- Dimitrios Iliopoulos · directorLast listed on the amended Form D that Proteas Bioanalytics filed on November 10, 2021; on 2 of its 3 filings.